346 related articles for article (PubMed ID: 15547201)
21. Metabolic response by FDG-PET to imatinib correlates with exon 11 KIT mutation and predicts outcome in patients with mucosal melanoma.
Zukotynski K; Yap JT; Giobbie-Hurder A; Weber J; Gonzalez R; Gajewski TF; O'Day S; Kim K; Hodi FS; Van den Abbeele AD
Cancer Imaging; 2014 Nov; 14(1):30. PubMed ID: 25609545
[TBL] [Abstract][Full Text] [Related]
22. Early response assessment in gastrointestinal stromal tumors with FDG PET scan 24 hours after a single dose of imatinib.
Shinto A; Nair N; Dutt A; Baghel NS
Clin Nucl Med; 2008 Jul; 33(7):486-7. PubMed ID: 18580237
[TBL] [Abstract][Full Text] [Related]
23. Radiologic assessment of earliest, best, and plateau response of gastrointestinal stromal tumors to neoadjuvant imatinib prior to successful surgical resection.
Tirumani SH; Shinagare AB; Jagannathan JP; Krajewski KM; Ramaiya NH; Raut CP
Eur J Surg Oncol; 2014 Apr; 40(4):420-8. PubMed ID: 24238762
[TBL] [Abstract][Full Text] [Related]
24. [Early response to treatment with Glivec detected with 18F-FDG PET in a patient with gastrointestinal stromal tumor].
Delgado Bolton RC; Ortega Candil A; Pérez Castejón MJ; Garcerant M; Cabrera Martín MN; Lapeña Gutiérrez L; Carreras Delgado JL
Rev Esp Med Nucl; 2008; 27(2):112-7. PubMed ID: 18367049
[TBL] [Abstract][Full Text] [Related]
25. Follow-up of hepatic and peritoneal metastases of gastrointestinal tumors (GIST) under Imatinib therapy requires different criteria of radiological evaluation (size is not everything!!!).
Mabille M; Vanel D; Albiter M; Le Cesne A; Bonvalot S; Le Péchoux C; Terrier P; Shapeero LG; Dromain C
Eur J Radiol; 2009 Feb; 69(2):204-8. PubMed ID: 19046841
[TBL] [Abstract][Full Text] [Related]
26. MDCT appearance of gastrointestinal stromal tumors after therapy with imatinib mesylate.
Warakaulle DR; Gleeson F
AJR Am J Roentgenol; 2006 Feb; 186(2):510-5. PubMed ID: 16423961
[TBL] [Abstract][Full Text] [Related]
27. Clonal evolution of resistance to imatinib in patients with metastatic gastrointestinal stromal tumors.
Desai J; Shankar S; Heinrich MC; Fletcher JA; Fletcher CD; Manola J; Morgan JA; Corless CL; George S; Tuncali K; Silverman SG; Van den Abbeele AD; van Sonnenberg E; Demetri GD
Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5398-405. PubMed ID: 17875769
[TBL] [Abstract][Full Text] [Related]
28. [FDG-PET and CT in gastrointestinal stromal tumor treated with imatinib].
Eigtved AI; Berthelsen AK; Kinnander C; Krarup-Hansen A
Ugeskr Laeger; 2003 Sep; 165(37):3507-9. PubMed ID: 14531350
[TBL] [Abstract][Full Text] [Related]
29. Comparison of PET, CT, and dual-modality PET/CT imaging for monitoring of imatinib (STI571) therapy in patients with gastrointestinal stromal tumors.
Antoch G; Kanja J; Bauer S; Kuehl H; Renzing-Koehler K; Schuette J; Bockisch A; Debatin JF; Freudenberg LS
J Nucl Med; 2004 Mar; 45(3):357-65. PubMed ID: 15001674
[TBL] [Abstract][Full Text] [Related]
30. PET scanning evaluation of response to imatinib mesylate therapy in gastrointestinal stromal tumor (GIST) patients.
Gelibter A; Milella M; Ceribelli A; Zeuli M; Ferraresi V; Vecchione A; Cognetti F
Anticancer Res; 2004; 24(5B):3147-51. PubMed ID: 15510603
[TBL] [Abstract][Full Text] [Related]
31. Imaging of gastrointestinal stromal tumors before and after imatinib mesylate therapy.
Shankar S; Dundamadappa SK; Karam AR; Stay RM; van Sonnenberg E
Acta Radiol; 2009 Oct; 50(8):837-44. PubMed ID: 19735005
[TBL] [Abstract][Full Text] [Related]
32. 18FDG-Positron emission tomography for the early prediction of response in advanced soft tissue sarcoma treated with imatinib mesylate (Glivec).
Stroobants S; Goeminne J; Seegers M; Dimitrijevic S; Dupont P; Nuyts J; Martens M; van den Borne B; Cole P; Sciot R; Dumez H; Silberman S; Mortelmans L; van Oosterom A
Eur J Cancer; 2003 Sep; 39(14):2012-20. PubMed ID: 12957455
[TBL] [Abstract][Full Text] [Related]
33. Value of FDG-PET for monitoring treatment response in patients with advanced GIST refractory to high-dose imatinib. A multicenter GEIS study.
Fuster D; Ayuso JR; Poveda A; Cubedo R; Casado A; Martínez-Trufero J; López-Pousa A; Del Muro XG; Lomeña F; Maurel J; Pons F
Q J Nucl Med Mol Imaging; 2011 Dec; 55(6):680-7. PubMed ID: 21150863
[TBL] [Abstract][Full Text] [Related]
34. Treatment response monitoring in patients with gastrointestinal stromal tumor using diffusion-weighted imaging: preliminary results in comparison with positron emission tomography/computed tomography.
Gong NJ; Wong CS; Chu YC; Gu J
NMR Biomed; 2013 Feb; 26(2):185-92. PubMed ID: 22806958
[TBL] [Abstract][Full Text] [Related]
35. PET/CT imaging of gastrointestinal stromal tumor with calcified peritoneal implants after imatinib therapy.
Eslamy HK; Quon A
Clin Nucl Med; 2008 Dec; 33(12):864-5. PubMed ID: 19033789
[TBL] [Abstract][Full Text] [Related]
36. Assessment of gastrointestinal stromal tumors with computed tomography following treatment with imatinib mesylate.
Phongkitkarun S; Phaisanphrukkun C; Jatchavala J; Sirachainan E
World J Gastroenterol; 2008 Feb; 14(6):892-8. PubMed ID: 18240346
[TBL] [Abstract][Full Text] [Related]
37. Gastrointestinal stromal tumor: role of CT in diagnosis and in response evaluation and surveillance after treatment with imatinib.
Hong X; Choi H; Loyer EM; Benjamin RS; Trent JC; Charnsangavej C
Radiographics; 2006; 26(2):481-95. PubMed ID: 16549611
[TBL] [Abstract][Full Text] [Related]
38. FDG PET and FDG PET/CT in patients with gastrointestinal stromal tumours.
Malle P; Sorschag M; Gallowitsch HJ
Wien Med Wochenschr; 2012 Oct; 162(19-20):423-9. PubMed ID: 22890522
[TBL] [Abstract][Full Text] [Related]
39. Gastrointestinal stromal tumor with metastases in an adult woman treated with imatinib mesylate: MDCT findings.
Busalacchi PJ; de la Calle MA; Torroba A; Del Río ST
AJR Am J Roentgenol; 2005 Mar; 184(3 Suppl):S58-61. PubMed ID: 15728023
[No Abstract] [Full Text] [Related]
40. FDG-PET and PET/CT in the clinical management of gastrointestinal stromal tumor.
Basu S; Mohandas KM; Peshwe H; Asopa R; Vyawahare M
Nucl Med Commun; 2008 Dec; 29(12):1026-39. PubMed ID: 18987522
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]